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Supplementary Information 
Material and Methods 
Materials 
Lyophilized L-α-phosphatidylcholine from soybean was purchased from 
Sigma-Aldrich. C12E8 was bought from Nikko Chemicals Co., LTD. Japan. 
[Cu(CH3CN)4]PF6, AMPPCP, and L-cysteine were obtained from Sigma-
Aldrich.  
Cloning and mutagenesis of LpCopA mutants 
Primer design and plasmids (pET22(+)) of the LpCopA mutants (M148V, 
D426N, C382A, C384A, C384S, C382S C384S, C382S C384S M717A, C18S 
C42S C56S C59S, Y688F, N689A, S721A) were prepared by site-directed 
mutagenesis using QuikChange® from Agilent Technologies. 
The heavy metal binding domain of LpCopA (residues 1 to 84, with an 
additional alanine in position 2) was cloned from the wild-type LpCopA [1] by 
the use of the forward primer sequence GCC CAT ATG GCT AAA CAC GAC 
CAC and the reverse primer sequence GCCC GC GGC CGC TTA TCG ACG 
TCT CAT ATC AAG ATA TTC and cloned into the pET22(+) vector.  
Sample preparation of wtLpCopA and mutants 
Protein expression, membrane preparation and the affinity chromatography 
with Ni-NTA for wtLpCopA, mutants, and ΔHMBDLpCopA (residues 1 to 73 
are missing) were performed as previously described with one slight 
modification [1], as the protein was directly transferred to Buffer E [20 mM 
MOPS-KOH pH=6.8, 80 mM KCl, 20% glycerol, 5 mM β-mercaptoethanol 
(BME), 1 mM MgCl2 and 0.28 mM C12E8] using a PD-10 desalting column (GE 
Healthcare) instead of a Superose 6 column. Typically, the mutants were 
concentrated to 5 to 10 mg/ml (Vivaspin, 50 kDa cutoff), flash frozen in 250 µl 
aliquots and stored at -80°C until further use.  
Protein purity and amount was checked by SDS-PAGE. Monodispersity of the 
mutant forms compared to wt protein was analyzed by a Superose 6 column 
(CV 24 ml). Protein of comparable monodispersity to the wt was utilized for all 
subsequent experiments. 
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Protein concentration was estimated from the absorption at 280 nm using a 
NanoDrop ND-1000 spectrophotometer (Thermo Scientifc), using an 
extinction coefficient of 59930 M-1 cm-1 for wtLpCopA and the mutants, while 
an extinction coefficient of 58440 M-1 cm-1 was used for the ΔHMBD LpCopA. 
 
HMBD expression and purification 
Recombinant HMBD of LpCopA was expressed in E. coli BL21 (DE3) GOLD 
cells. Transformed cells were grown at 37 °C in TB-Glycerol media containing 
50 mg/l ampicillin until an OD600 = 1 was reached, cooled at 30 °C and protein 
expression was induced by addition of 1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG). Cells were harvested after 4 h post-induction 
by centrifugation (9000g, 4 °C, 20 min) and cell pellets were stored at -80 °C 
until further use. Cells were suspended in 20 mM Tris-HCl pH = 8, 500 mM 
NaCl, 5mM MgCl2, 1 mM DTT supplemented with 30 g/ml of DNaseI from 
bovine pancreas (Sigma-Aldrich) and EDTA-free protease inhibitor cocktail 
(Roche) to a final concentration of 0.1 g cells/ml. Typically 20 g cells were 
disrupted by 3-pass cycles in a microfluidizer operating at a pressure of 
18000-20000 psi. Cell debris was removed by centrifugation (15900g, 4°C, 30 
min). Supernatant was collected and buffer composition subsequently 
adjusted to 20 mM Tris-HCl pH=8, 500 mM NaCl, 5 mM MgCl2, 1 mM DTT 
and 25 mM imidazole. The protein was purified by affinity chromatography 
upon supernatant incubation with 5 ml Ni-NTA beads for 2 h at 4 °C under 
stirring. Resin was loaded on a gravity column and beads washed with 30 
column volumes of 20 mM Tris-HCl pH = 8, 500 mM NaCl, 25 mM imidazole, 
1 mM DTT and protein eluted in 20 mM Tris-HCl pH=8, 250 mM NaCl, 250 
mM imidazole, 1 mM DTT. Protein containing fractions were pooled and 
further purified by size-exclusion chromatography with a Superdex 75 10/30 
column eluted with 20 mM Tris-HCl pH=8, 250 mM NaCl, 1 mM DTT, 1 mM 
EDTA. The peak corresponding to monomeric protein was collected, flash 
frozen in liquid N2 and stored at -80 °C. Protein concentration was determined 
by absorption spectroscopy using an extinction coefficient of 2980 M-1 cm-1. 
 
Determination of Cu+ binding stoichiometry 
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Protein stocks and all solutions were made oxygen-free on a Schlenk-line via 
eight vacuum-argon cycles. Sample preparation was performed in an argon 
(90%)-hydrogen (10%) purged Coy anaerobic chamber equipped with 
palladium catalyst cassettes for removal of residual molecular oxygen. All 
buffers and stock solutions were treated with Chelex-100 resin before use to 
remove metal traces. 
Protein stocks were diluted into Buffer E and the buffer was exchanged to a 
final Buffer E without BME. Additionally, to a subset of the LpCopA variants, 
final concentrations of 20 mM cysteine and 1 mM nucleotide were prepared. 
Copper binding was achieved by addition to the protein of an excess (6 Cu+ 
eq.) of a freshly prepared stock solution of [Cu(CH3CN)4]PF6 dissolved in 
CH3CN. Free or loosely bound metal was removed using a 5 ml Hi Trap 
desalting column packed with Sephadex G-25 resin (GE Healthcare, USA). 
Cu+ content was determined by ICP-MS as indicated below. Protein 
concentration was estimated by absorption spectroscopy at 280 nm and 
independently using a Bradford assay in 96-well plate format using bovine 
serum albumin as a standard. 96-well plate absorbance measurements at 595 
nm were performed on a Tecan Infinite M200 instrument. 
Determination of Cu+ stoichiometry to the isolated HMBD was performed on 
samples prepared for XAS measurements. 
XAS sample preparation 
All buffers and stock solutions were treated with Chelex-100 resin before use 
to remove metal traces. HMBD of LpCopA, wt and ΔHMBD LpCopA samples 
and stock solutions for XAS were rendered oxygen-free on a Schlenk line and 
all sample preparation steps were performed in an argon (90%)-hydrogen 
(10%) purged glove-box equipped with palladium catalyst cassettes. Two 
different reconstitution procedures were undertaken for wt/ΔHMBD LpCopA 
and HMBD. 
Wt and ΔHMBD LpCopA stocks (approx. 20 mg/ml) were diluted 50 times in 
20 mM Tris-HCl pH=7.6, 200 mM KCl, 1 mM MgCl2, 0.15 mg/ml C12E8, 
20 %(w/v) glycerol, and copper reconstitution performed by addition of a 
freshly prepared stock solution of [Cu(CH3CN)4]PF6 dissolved in CH3CN at the 
final Cu+:protein stoichiometry  (1:1, 1:2 for ΔHMBD,  and 1:1 and 1:4 for 
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wtLpCopA). Samples were subsequently concentrated using Amicon-Ultra 50 
kDa cutoff membrane concentrators to a final concentration of 0.4 - 0.6 mM.  
The HMBD reconstitution was performed in an oxygen-free glovebox by apo-
protein preparation via acid treatment to remove residual zinc bound to the 
protein through the expression and purification, as determined by ICP-MS 
analysis. An HMBD stock solution (~150 µM) was acidified to pH = 1-2 by 
addition of a 1 M HCl stock and immediately desalted using a 5 ml Hi-Trap 
desalting column packed with Sephadex G-25 resin (GE Healthcare, USA) 
eluted with 10 mM HCl. Copper reconstitution was performed by addition of a 
freshly prepared stock solution of [Cu(CH3CN)4]PF6  dissolved in CH3CN at 
the final desired Cu+:protein stoichiometry  (1:1 and 1:2) and buffer adjusted 
to final 50 mM Tris-HCl pH=8, 250 mM NaCl. Samples were subsequently 
concentrated using Amicon-Ultra 3 kDa cutoff membrane concentrators. Final 
metal-to-protein ratios were determined by ICP-MS upon metal release as 
reported below. 
XAS data collection and analysis 
Samples were loaded into custom-made polycarbonate XAS sample cells 
sealed with metal-free tape in the anaerobic glove box, flash frozen in liquid 
nitrogen and stored in liquid nitrogen until data collection. X-ray absorption 
spectroscopy measurements were performed at the Stanford Synchrotron 
Radiation Laboratory with the SPEAR-3 storage ring operating at 350 mA at 
3.0 GeV. Copper K-edge data were collected using beamline 7-3 with a 
wiggler field of 2 Teslas and employing an Si(220) double-crystal 
monochromator and a vertically-collimating pre-monochromator harmonic 
rejection mirror. The incident and transmitted X-ray intensities were monitored 
using nitrogen-filled ionization chambers, and X-ray absorption was measured 
as the copper Kα fluorescence using an array of 30 germanium detectors. 
Nickel filters were placed between the cryostat and detector to reduce 
scattered X-ray not associated with copper fluorescence. During data 
collection, samples were maintained at a temperature of ~10 K using an 
Oxford Instruments liquid helium flow cryostat. XAS spectra were measured 
using 10- eV step in the pre-edge region (8750–8960 eV), 0.35 eV steps in 
the edge region (8960–9010 eV) and 0.05 Å−1 increments in the EXAFS 
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region (to k = 13.1 Å−1). Two to five ~40-min scans were accumulated, and 
the energy was calibrated by reference to the absorption of a standard copper 
metal foil measured simultaneously with each scan, assuming a lowest 
energy inflection point of the copper foil to be 8980.3 eV. 
The EXAFS oscillations (k) were quantitatively analyzed by curve fitting using 
the EXAFSPAK suite (George, G.N., EXAFSPAK, 
http://ssrl.slac.stanford.edu/exafspak.html).  Ab initio theoretical phase and 
amplitude functions were calculated using the program FEFF version 8.2 [2]. 
Data obtained from each Ge-detector element were checked for spectral 
anomalies and data from elements showing abnormal responses were 
excluded from data averaging. No smoothing, filtering, or related operations 
were performed on the data. 
ICP-MS analysis 
For ICP-MS, protein samples were mixed with concentrated HNO3 (69 %(w/v)) 
to obtain a HNO3 concentration of 10 %(w/v), and digested at 80 °C for 2 h -
16 h hours. Samples were subsequently diluted to a final concentration of 
1 %(w/v) HNO3. ICP-MS has been performed on a Hewlett-Packard 4500 ICP 
mass spectrometer (Agilent Technologies, Caltech Environmental Analysis 
Center) connected to CETAC ASX-500 auto-sampler for sample injection. The 
corresponding buffers have been used for background blank subtraction. 
High-purity TraceSelect nitric acid, CuCl2 standard solutions and TraceSelect 
H2O were from Sigma-Aldrich. 
ATP hydrolysis assay 
ATPase activity in a lipid-detergent solution environment was measured by a 
modified colorimetric phosphate detection method introduced by Baginski with 
bismuth detection under aerobic conditions[3] in a 96-well plate. 
wtLpCopA (15 µg, 4 µM final concentration), or one of the mutants, was mixed 
with reaction buffer [40 mM MOPS-KOH pH = 6.8, 150 mM NaCl, 5 mM KCl, 
5 mM MgCl2, 20 mM (NH4)2 SO4, 1.2 mg/ml L-α-phosphatidylcholine, 3 mg/ml 
C12E8, 20 mM L-cysteine, 5 mM NaN3, 0.25 mM Na2MoO4, 0.01 mM 
[NH4]2MoS4] in a total volume of 50 µl. Either 1 µl of  25 mM CuCl2 (0.5 mM 
final concentration) or 5 µl of a 10x stock of different CuCl2 concentrations 
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from a dilution series (0 and 20 mM) was added. The reaction was initiated by 
the addition of a 10x stock of different ATP concentrations from a dilution 
series (0 to 100 mM) in the case of a fixed concentration of CuCl2 (0.5 mM) in 
the reaction mixture, or by 2 µl of 125 mM ATP (5 mM final concentration) in 
the case of the CuCl2 concentration variation. The reaction was incubated for 
30 min at 37 °C and stopped by the addition of 75 µl of freshly prepared 
development solution (2.86 %(w/v) ascorbic acid, 1 M HCl, 0.48 %(w/v) 
(NH4)2MoO4, 2.86 %(w/v) SDS). The color development was stopped with 125 
µl of stop solution (3.5 %(w/v) bismuth citrate, 3.5%(w/v) sodium citrate, 1 M 
HCl) and the absorption was measured at 710 nm on a VICTOR 3 1420 
Multilabel Plate Reader (PerkinElmer). At least three independent 
measurements for each condition were performed. For a phosphate (Pi) 
standard curve, increasing KH2PO4 concentrations (0 to 0.4 mM) were 
measured in triplicates on each plate with a total volume of 50 µl. 
 
Statistical analysis of ATPase activity 
Statistical analysis was performed using KaleidaGraph v4.1.3 for MacOSx 
(Synergy Software). Cu+/ATP independent background activity was 
subtracted from the 0 mM CuCl2/ATP values.  
Specific ATPase activity was calculated by the use of equation 1: 
(1) 
Where v corresponds to the specific activity given in nmol Pi/mg protein/min, 
Abs710 is the background-corrected measured absorption, mpi allocates the 
slope of the phosphate standard curve in µM, c is the measured protein 
concentration in mg/ml and t is the incubation time (30 min).  
The mean value and its corresponding standard deviation was calculated with 
KaleidaGraph v4.1.3 and systematic errors from the protein concentration and 
the phosphate standard curve where incorporated in the final data. The 
calculated data were plotted against the CuCl2 or ATP concentration and 
curve fitting was performed using a Michaelis-Menten enzyme kinetics 
reaction with KaleidaGraph v4.1.3 (2): 
v = Abs710mPi *c* t
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 (2) 
Data statistics are reported with the mean value and the standard error. 
Physical outliers (negative absorption) have been removed from the curve 
fitting and the experimental measurement errors (σi) were used to weight 
particular experimental points in the data set.  
Charge transfer measurements on solid supported membranes 
E. coli membrane fragments, enriched with wtLpCopA and selected mutants, 
were prepared by the membrane isolation protocol previously described [1]. 
Thereafter, to remove loosely bound contaminant proteins from the 
membrane fraction the membranes were suspended (15 mL/g) in washing 
buffer containing 20 mM Tris-HCl pH=7.6, 1500 mM KCl, 20% glycerol, 5 mM 
BME, 1 mM MgCl2 and 0.1 mg/mL C12E8. The membranes were then isolated 
by ultracentrifugation at 250000 xg for 5 hours and resuspended (15 mL/g ) in 
20 mM Tris-HCl pH=7.6, 200 mM KCl, 20% glycerol, 5 mM BME and 1 mM 
MgCl2. LpCopA bands were quantified on a SDS-PAGE gel using the 
software ImageJ. Subsequently, the LpCopA concentrations in the different 
samples were equalize by dilution in suspension buffer.  
The membrane fragments were adsorbed on an SSM during an incubation 
time of 60 minutes. The SSM consists of an alkanethiol monolayer covalently 
bound to a gold electrode via the sulfur atom, and further coated with a 
phospholipid monolayer. Following adsorption, wtLpCopA or mutants were 
activated by an ATP concentration jump. If the ATP jump induces a net 
charge movement within the protein, a current transient is recorded due to the 
capacitive coupling between membrane fragment and SSM [4, 5].  The 
method allows electrogenic steps of the first catalytic cycle to be detected, 
and is not sensitive to steady-state currents [4, 5].  
The buffer solution contained 150mM NaCl, 5mM KCl, 5mM MgCl2, 40mM 
MOPS, pH 6.8 (KOH), 5mM NaN3, 20mM cysteine, and 0.5mM CuCl2 or 
10µM ammonium-tetrathiomolybdate (TTM) (as copper chelator). ATPase 
activation was obtained by rapidly exchanging the buffer solution with an 
identical buffer solution containing 100µM ATP. 
v = vmax[s]Km +[s]
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The concentration jump experiments were carried out by employing the 
SURFE2ROne device (Nanion Technologies, Munich, Germany). The 
temperature was maintained at 22-23 °C for all the experiments.  
Each measurement was repeated 6 times (two minute waiting time after each 
measurement) and averaged to improve the signal to noise ratio. Standard 
deviations did not exceed 5%. Moreover, each set of measurements was 
typically reproduced using 2-3 different SSM electrodes. 
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Supplementary Figures 
Supplementary Figure 1 Sequence alignment between Legionella 
Pneumophila CopA and Archaeoglobus Fulgidus CopA. 
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The conserved residues are highlighted in red and similar residues in red 
boxes.  
The proposed TM metal binding residues discussed in the text are highlighted 
by blue arrows, while the conserve “entry-site” methionine by a blue circle. 
The figure has been generated with Espript 3.0 [6]. 
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Supplementary Figure 2: Electronic absorption (UV-Vis) spectra of 
LpCopA titrated with Cu+.   
 [Cu(CH3CN)4]PF6 (0.25 eq. until 4 eq./LpCopA was reached, afterwards 1 
eq./LpCopA until 6 eq./LpCopA) was titrated to the wild-type LpCopA (5.5 µM) 
and a spectral scan was recorded after each titration on a Varian Cary UV-Vis 
spectrophotometer. A metal-induced transitions envelope centered around 
240-260 nm overlaying backbone and aromatic residues contributions 
occurred at low Cu-LpCopA ratios (<3-4) in agreement with formation of 
CysS-Cu+ ligands-to-metal charge transfer transitions. However this was 
followed by increasing light scattering (as monitored at 420 mm) when 4-6 
equivalents of Cu+ were added to the wild-type LpCopA indicating the 
susceptibility to erroneous Cu+ binding and consequent aggregation in 
absence of weak chelators. A small absorbance jump due to source 
changeover at 340 nm has been corrected.  
Similar indications were obtained upon Cu+ to protein stoichiometry 
determinations conducted upon titration of LpCopA followed by size-exclusion 
and Cu+ quantification by ICP-MS. The amount of copper bound was 
significantly higher than the expected binding sites anticipated by the 
available crystal structure as well from binding based on AfCopA studies. We 
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reasoned that LpCopA is sensitive to precipitation in absence of chelators and 
the complete set of experiments was thus performed in the presence of 
cysteine.  
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Supplementary Figure 3: Determination of Cu+-binding stoichiometry in 
wtLpCopA and its nucleotide-analogue (AMPPCP) bound state by 
inductively coupled plasma mass-spectrometry.  
The wtLpCopA was incubated with Cu+ as described in the Material and 
Methods section. Additionally 1 mM nucleotide analogue was added. Cu+-
binding stoichiometry was determined upon Cu+ reconstitution of protein 
samples in anaerobic atmosphere and removal of metal excess by size-
exclusion chromatography. Protein concentrations were determined by 
Bradford method and Cu+ content by ICP-MS. 
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Supplementary Figure 4: Determination of Cu+- and Zn2+- binding 
stoichiometry in wtLpCopA and ΔHMBDLpCopA (XAS samples) 
compared to purified N-terminal HMBD.  
Protein concentrations were determined by absorption of their aromatic 
residues at  280 nm and Cu+ and Zn2+ content by ICP-MS. 
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Supplementary Figure 5: First derivative of the XANES spectra of 
LpCopA- Cu+. 
The first derivative of the XANES spectra of ΔHMBDCopA-Cu+ (Cu+:protein 
1:1 or 1:2) and wtLpCopA (Cu+:protein 1:1 or 1:4) shows the first primary 
inflection points at essentially the same energy (~8981 eV, indicated by the 
dotted line) and intensity, in agreement with the presence of Cu+ sites with 
very similar coordination. 
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Supplementary Figure 6: XANES spectra of LpCopA-Cu+, ΔHMBDCopA- 
Cu+ and HMBD-Cu+. 
Normalized XANES spectra of wtLpCopA-Cu+ (Cu+:protein 1:1, blue line; 
Cu+:protein 4:1, magenta line) and ΔHMBDCopA-Cu+ (Cu+:protein 1:1, black 
line; Cu+:protein 2:1 red line) in 20 mM Tris-HCl pH=7.6, 200 mM KCl, 1 mM 
MgCl2, 0.15 mg/ml C12E8, 20% glycerol. These spectra are compared to the 
normalized XANES spectra of HMBD-Cu+ (Cu+:protein stoichiometry 1:1, 
black line) and HMBD-Cu+ (Cu+:protein 2:1, red line) in 50 mM Tris-HCl, 250 
mM NaCl pH=8. The peak position of the 1s→4p transition at 8983 eV is 
indicated by the dotted line. 
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Supplementary Figure 7: Cu K-edge EXAFS and Fourier transforms of 
ΔHMBDCopA and wtLpCopA. 
Experimental EXAFS data (black line) and best fits (red line) (A,C), and the 
corresponding Fourier transforms (B,D) for saturated ΔHMBDCopA-Cu+ (A) 
(Cu+:protein stoichiometry 2:1), and wtLpCopA-Cu+ (Cu+:protein stoichiometry 
1:1) (C) in 20 mM Tris-HCl pH=7.6, 200 mM KCl, 1 mM MgCl2, 0.15 mg/ml 
C12E8, 20 %(w/v) glycerol. The parameters for the best fits are listed in Table 
II. 
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Supplementary Figure 8: Cu+ K-edge EXAFS and corresponding Fourier 
transforms of HMBD of LpCopA. 
Experimental EXAFS data (black line) and best fits (red line) (A,C), and 
corresponding Fourier transforms (B,D) for HMBD-Cu+ (Cu+:protein 
stoichiometry 1:1) (A) and HMBD-Cu+ (Cu+:protein stoichiometry 2:1) (C) in 50 
mM Tris-HCl, 250 mM NaCl pH=8. The parameters for the best fits are listed 
in Supplementary Table II. 
 
	   19	  
Supplementary Table I: Extended X-ray absorption fine structure (EXAFS) 
curve-fitting results for ΔHMBDLpCopA.  
 
Protein 
Cu+ eq. 
added 
Scattering 
Paths 
N R (Å) σ2 (Å2) F 
ΔHMBD LpCopA  
1 
Cu-S 2 2.249(4) 0.0030(4) 
0.298 Cu-S 1 2.270(4) 0.009(3) 
Cu···Cu 1 2.707(6) 0.0051(4) 
Cu-S 2 2.263(4) 0.0024(2) 
0.305 Cu-N/O 1 2.060(2) 0.003(1) 
Cu···Cu 1 2.712(5) 0.0056(4) 
Cu-S 1 2.293(6) 0.0014(5)1 
0.332 Cu-N/O 2 2.116(5) 0.0009(5) 1 
Cu···Cu 1 2.741(6) 0.0057(5) 
2 
Cu-S 2 2.228(4) 0.0075(1) 
0.192 Cu-S 1 2.262(3) 0.005(2) 
Cu···Cu 1 2.702(3) 0.0069(3) 
Cu-S 2 2.261(2) 0.0020(1)  
0.197 Cu-N/O 1 2.030(1) 0.005(1) 
Cu···Cu 1 2.711(4) 0.0072(4) 
Cu-S 1 2.290(4) 0.0015(3)1 
0.254 Cu-N/O 2 2.125(3) 0.0010(4) 1 
Cu···Cu 1 2.746(5) 0.0078(5) 
 
Coordination numbers are indicated by N, interatomic distances R are given in 
Å (the values in parentheses are the estimated standard deviations), Debye-
Waller factors σ2 (the mean-square deviations in interatomic distance, the 
values in parentheses are the estimated standard deviations) in Å2, and the 
fit-error function F is defined by F 
= ∑ k6(χ (k)calcd – χ (k)exp)2 /∑ k6χ (k)exp2  where χ (k) are the EXAFS 
oscillations and k is the photo-electron wave number.  
1 The Debye-Waller factors have been linked in the fitting to prevent free 
floating of Cu-S to negative values. 
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Supplementary Table II: Extended X-ray absorption fine structure (EXAFS) 
fitting results for HMBD-Cu+. 
 
Protein 
Cu+ eq. 
added 
Scattering 
Paths 
N R (Å) σ2 (Å2) F 
HMBD 
1 
Cu-S 3 2.249(3) 0.0047(2) 
0.363 
Cu···Cu 1 2.682(7) 0.0071(7) 
2 
Cu-S 3 2.237(3) 0.0044(1) 
0.320 
Cu···Cu 1 2.654(7) 0.0081(7) 
 
Coordination numbers are indicated by N, interatomic distances R are given in 
Å, Debye-Waller factors σ2 (the mean-square deviations in interatomic 
distance) in Å2, and the fit-error function F is defined by F 
= ∑ k6(χ (k)calcd – χ (k)exp)2 /∑ k6χ (k)exp2  where χ (k) are the EXAFS 
oscillations and k is the photo-electron wave number. The values in 
parentheses are the estimated standard deviations. 
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Supplementary Table III: ATPase activity by LpCopA and mutants 
determined as a function of Cu+ concentration. 
 
 K1/2,Cu (mM) vmax (nmol mg-1 min-1) Fitting (R) 
wt LpCopA 0.0006 ± 0.0002 19.8 ± 0.7 0.97 
ΔHMBD LpCopA 0.11 ± 0.02 5.7 ± 0.3 0.96 
LpCopA D426N (1.6 ± 1.1) 2.6 ± 1.0 0.97 
LpCopA C18S C42S C56S C59S (0.5 ± 2.4) 3 ± 61 0.89 
LpCopA M148V (0.008 ± 0.004) 1.2 ± 0.11 0.93 
LpCopA C382S C384S (0.16 ± 0.05) 2.2 ± 0.21 0.99 
LpCopA C382S C384S M717A (0.7 ± 0.2) 1.6 ± 0.21 0.98 
1 Data are comparable to D426N. Residual activity is not accurately measurable.  
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Supplementary Table IV: ATPase activity by LpCopA and mutants 
determined as a function of ATP concentrations. 
 
 K1/2,ATP (mM) vmax (nmol mg-1 min-1) Fitting (R) 
wt 0.29 ± 0.02 17.5 ± 0.4 1.0 
ΔHMBD 0.59 ± 0.04 7.1 ± 0.1 0.96 
D426N (5.5 ± 1.6) 3.9 ± 0.6 0.94 
C18S C42S C56S C59S (0.26 ± 0.04) 5.7 ± 0.22 0.96 
M148V (0.7 ± 0.2) 5.9 ± 0.72 0.98 
C382S C384S1 (2.2 ± 1.7) 3 ± 12 0.89 
C382S C384S M717A (7.7 ± 2.9) 5.3 ± 1.32 0.98 
1 Data are not weighted according to their experimental error. 
2 Data are comparable to D426N. Residual activity is not accurately measurable. 	  
